Navigation Links
27-Year Pharmaceutical Marketing Leader Ruth Desmond Joins Stream57
Date:1/13/2009

a more ideal candidate to lead our healthcare initiatives. Ruth's endorsement by way of embracing and promoting our technology was the most flattering and humbling praise to receive; we couldn't be more excited about where her influence and reputation will take us now."

Dr. Desmond joins Stream57 as the company comes off a banner year. In 2008, Stream57 nearly doubled in size, executed first-time projects for several new industries such as publishing and consumer product marketing, and received multiple awards and accolades including a prize at the Medical Marketing & Media Awards.

"One of my favorite quotes is from the great philosopher, Wayne Gretzky. I think he also played a little hockey," Desmond joked. "He said, 'I skate to where the puck is going to be, not where it is.' Right now, the puck is blazing toward multi-channel marketing and nobody does it better than Stream57."

For interviews or additional information, please contact Andrew Parker at 212-909-2550 x1020 or aparker@s57.com.

About Stream57

Stream57 is an energetic team that believes in the power of the Internet for learning, marketing and entertainment, with offices in New York and London. StreamLine 2.9.5, Stream57's cutting-edge webcast and rich media software suite, brings a new level of interactivity to online video presentations and e-learning. Recently named #745 in the Inc. 5000 List of Fastest Growing Private Companies, Stream57 was founded in 2001 by President Ben Chodor, and has provided software and services for rich media delivery, webcasting and e-learning solutions for a wide range of distinguished clients, including several Fortune 1000 corporations, charities, B2B publishers, higher education institutions and healthcare organizations. For more information on Stream57, please call 21
'/>"/>

SOURCE Stream57
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... issue of Experimental Biology and Medicine ... Gaskins and Paul Kenis in the Institute of ... University of Illinois Urbana-Champaign describe their recent work ... a variety of cell functions including energy metabolism, ... roles in regulating normal cellular behavior, redox status ...
(Date:4/17/2014)... McCullers, MD, was recently invited to submit a ... Reviews Microbiology , one of the world,s foremost ... disease specialist, and chair of the Department of ... Center, analyzed the epidemiology and microbiology of co-infections ... well as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... many as 10 million older Americans suffer from depression, ... , However, new research a project that followed ... six years found that Internet use among the ... than 30 percent. , "That,s a very strong effect," ... telecommunication, information studies and media who led the project. ...
(Date:4/17/2014)... of Medicine (BUSM) have discovered that the anti-seizure ... model. The findings, reported in the American ... lead to more effective treatments for alcoholism. , ... leading causes of illness and death in the ... limiting the productivity of workers and necessitating huge ...
(Date:4/17/2014)... A. Arias, M.D., Ph.D., at The University of Texas ... new superbug that caused a bloodstream infection in a ... issue of The New England Journal of Medicine ... class of highly-resistant bacteria known as methicillin-resistant Staphylococcus ... of hospital and community-associated infections. The superbug has also ...
Breaking Medicine News(10 mins):Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:New MRSA superbug emerges in Brazil 2
... may not be any more effective than giving them ... study.// ,Researchers studied 100 children with upper ... a common ingredient found in over-the-counter cough medicines. Another ... 34 children were given a placebo. ,Results of ...
... that’s responsible for controlling the activated leukocyte cell adhesion molecule ... cells stay clumped together. The gene is less active in ... don’t result in a spreading of the disease. Researchers speculate ... to more easily separate and migrate to other areas of ...
... the immune system may play a key role in women ... percent of all conceptions // fail, and around 1 percent ... many of the cases are due to fetal abnormalities, others ... research links the reproductive hormone secretion system to the immune ...
... SARS vaccine may be on the horizon. Researchers from ... a study involving eight African green monkeys. Four of ... using an intranasal vaccine made from a parainfluenza vaccine ... express a major antigen of the coronavirus that causes ...
... is a drop in blood pressure, say researchers, according ... on the association between blood pressure and Alzheimer’s disease ... on blood pressure variations before and after a diagnosis ... who were 75 or older. The participants had no ...
... down the progression of HIV, according to new research. Researchers ... progression of this deadly disease. Past studies have indicated that ... HIV. However researchers recently conducted a study to determine if ... included 1,078 pregnant women who were infected with HIV. The ...
Cached Medicine News:
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Novagali Pharma, an,emerging pharmaceutical company specialized in ophthalmology,presents ... trial,positive results from the Phase III clinical study ... at the,XIV Afro-Asian Congress of ophthalmology (AACO) held ... , VKC is a severe form of chronic ...
... Interim results in a randomized phase II/III ... 26, 2007 /PRNewswire-FirstCall/ -- Cell,Therapeutics, Inc. (CTI) ... that treatment with pixantrone (BBR,2778) resulted in ... mitoxantrone induced significant cardiac damage.,The studies compared ...
Cached Medicine Technology:Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 2Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 3Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: